We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Germline and somatic genetic testing in ovarian cancer patients.
- Authors
Chandrasekaran, D.; Manchanda, R.
- Abstract
The article focuses on genetic testing for germline BRCA1/BRCA2 mutations in epithelial ovarian cancer (EOC) which can benefit from targeted therapy such as poly adenosine diphosphate (ADP) ribose polymerase inhibitors. It mentions risk mutation carriers access to opportunities for screening and chemoprevention selective estrogen receptor modulators for breast cancer. It also mentions importance of offering genetic testing to all women.
- Subjects
GENETIC testing; GERM cells; BRCA genes; OVARIAN epithelial cancer; ADENOSINE diphosphate ribose; CHEMOPREVENTION; SELECTIVE estrogen receptor modulators; BREAST cancer; OVARIAN tumors; PROTEINS
- Publication
BJOG: An International Journal of Obstetrics & Gynaecology, 2018, Vol 125, Issue 11, p1460
- ISSN
1470-0328
- Publication type
Academic Journal
- DOI
10.1111/1471-0528.15225